Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in…

Overview of attention for article published in Diabetes Therapy, September 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 37 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,221 followers.

Online now in #Diabetes Therapy: Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with... http://t.co/IU360vMhiZ #OA

Reply Repost Favourite